Literature DB >> 10756976

Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes.

K R Gee1, K A Brown, W N Chen, J Bishop-Stewart, D Gray, I Johnson.   

Abstract

We have developed fluo-4, a new fluorescent dye for quantifying cellular Ca2+ concentrations in the 100 nM to 1 microM range. Fluo-4 is similar in structure and spectral properties to the widely used fluorescent Ca(2+)-indicator dye, fluo-3, but it has certain advantages over fluo-3. Due to its greater absorption near 488 nm, fluo-4 offers substantially brighter fluorescence emission when used with excitation by argon-ion laser or other sources in conjunction with the standard fluorescein filter set. In vitro, fluo-4 exhibited high fluorescence emission, a high rate of cell permeation, and a large dynamic range for reporting [Ca2+] around a Kd(Ca2+) of 345 nM. We have also developed several Ca(2+)-indicators related to fluo-4 having lower affinities for Ca2+ that are useful in cellular studies requiring quantification of higher [Ca2+]. In a variety of physiological studies of live cells, fluo-4 labeled cells more brightly than did fluo-3, when challenged with procedures designed to elevate calcium levels. Fluo-4 is well suited for photometric and imaging applications that make use of confocal laser scanning microscopy, flow cytometry, or spectrofluorometry, or in fluorometric high-throughput microplate screening assays. Because of its higher fluorescence emission intensity, fluo-4 can be used at lower intracellular concentrations, making its use a less invasive practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756976     DOI: 10.1054/ceca.1999.0095

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  164 in total

Review 1.  Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Authors:  Steven J Charlton; Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Loss of calcium in human spermatozoa via EPPIN, the semenogelin receptor.

Authors:  Michael G O'Rand; Esther E Widgren
Journal:  Biol Reprod       Date:  2012-02-29       Impact factor: 4.285

Review 3.  Matching models to data: a receptor pharmacologist's guide.

Authors:  David A Hall; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

4.  TAT-mediated photochemical internalization results in cell killing by causing the release of calcium into the cytosol of cells.

Authors:  Nandhini Muthukrishnan; Gregory A Johnson; Jongdoo Lim; Eric E Simanek; Jean-Philippe Pellois
Journal:  Biochim Biophys Acta       Date:  2012-07-03

5.  A Simple, Versatile Antibody-Based Barcoding Method for Flow Cytometry.

Authors:  Billur Akkaya; Pietro Miozzo; Amanda H Holstein; Ethan M Shevach; Susan K Pierce; Munir Akkaya
Journal:  J Immunol       Date:  2016-07-20       Impact factor: 5.422

6.  Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii.

Authors:  Kisaburo Nagamune; Wandy L Beatty; L David Sibley
Journal:  Eukaryot Cell       Date:  2007-08-31

7.  Neuron type-specific effects of brain-derived neurotrophic factor in rat superficial dorsal horn and their relevance to 'central sensitization'.

Authors:  Van B Lu; Klaus Ballanyi; William F Colmers; Peter A Smith
Journal:  J Physiol       Date:  2007-08-30       Impact factor: 5.182

8.  Initiation and propagation of ectopic waves: insights from an in vitro model of ischemia-reperfusion injury.

Authors:  Ara Arutunyan; Luther M Swift; Narine Sarvazyan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

9.  Pharmacological profile of store-operated channels in cerebral arteriolar smooth muscle cells.

Authors:  R Flemming; S Z Xu; D J Beech
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

10.  TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure.

Authors:  Rebecca M Sappington; Tatiana Sidorova; Daniel J Long; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.